NewAmsterdam Pharma Company
NAMS
$23.42
Share price
-0.76%
Change (1 day)
35.77%
Change (1 year)
Categories
Operating Margin for NewAmsterdam Pharma Company (NAMS)
Operating Margin as of July 2025 (TTM): -542.92%
According to NewAmsterdam Pharma Company's latest financial reports and stock price the company's current Operating Margin is -542.92%. At the end of 2024 the company had an Operating Margin of -530.25%.
Operating Margin history for NewAmsterdam Pharma Company from 2023 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -530.25% | -57.77% |
| 2023 | -1,255.57% | 5596.72% |
| 2022 | -22.04% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.